Microbiome and pancreatic ductal adenocarcinoma.
Dysbiosis
Fungi
Intratumor bacteria
Microbiota
Pancreatic cancer
Journal
Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
31
10
2020
accepted:
24
11
2020
pubmed:
20
2
2021
medline:
15
12
2021
entrez:
19
2
2021
Statut:
ppublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) incidence and related-deaths are increasing worldwide. PDAC is characterized by poor prognosis due to late diagnosis, high metastatic capacity and resistance to therapy. This is partially due to its specific microenvironment, where the stroma is prominent over tumor cells. Besides the oral and gut microbiota, the intratumor microbiome, i.e. the bacterial and fungal microorganisms present within the tumor, was recently introduced as a new partner of the tumor microenvironment of PDAC modulating pancreatic carcinogenesis, intratumor immune infiltrates, and response to chemotherapy. In this review, we propose an overview of current knowledge about the roles of bacteria and fungi in PDAC development and biology, and discuss potential therapeutic implications.
Identifiants
pubmed: 33607375
pii: S2210-7401(20)30355-7
doi: 10.1016/j.clinre.2020.101589
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101589Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.